117 related articles for article (PubMed ID: 32815673)
1. Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy.
Čamdžić N; Kuskunović-Vlahovljak S; Dorić M; Radović S; Lazović Salčin E; Babić M
Med Glas (Zenica); 2021 Feb; 18(1):122-127. PubMed ID: 32815673
[TBL] [Abstract][Full Text] [Related]
2. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
Horninger W; Cheli CD; Babaian RJ; Fritsche HA; Lepor H; Taneja SS; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Bartsch G
Urology; 2002 Oct; 60(4 Suppl 1):31-5. PubMed ID: 12384160
[TBL] [Abstract][Full Text] [Related]
3. Association of Gleason score with PSA Values and Serum Testosterone Levels Measured Prior To Prostate Biopsy.
Temel MC; Ediz C; Akan S; Ozer E; Yilmaz O
J Coll Physicians Surg Pak; 2020 Apr; 30(4):399-402. PubMed ID: 32513360
[TBL] [Abstract][Full Text] [Related]
4. Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen.
Gao HW; Li YL; Wu S; Wang YS; Zhang HF; Pan YZ; Zhang L; Tateno H; Sato I; Kuwahara M; Zhao XJ
Asian J Androl; 2005 Jun; 7(2):159-63. PubMed ID: 15897972
[TBL] [Abstract][Full Text] [Related]
5. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
[TBL] [Abstract][Full Text] [Related]
6. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
[TBL] [Abstract][Full Text] [Related]
7. Serum free prostate-specific antigen in the diagnosis of prostate cancer.
Leung HY; Lai LC; Day J; Thomson J; Neal DE; Hamdy FC
Br J Urol; 1997 Aug; 80(2):256-9. PubMed ID: 9284198
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
[TBL] [Abstract][Full Text] [Related]
9. Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.
Stimac G; Spajic B; Reljic A; Katusic J; Popovic A; Grubisic I; Tomas D
Korean J Urol; 2014 Aug; 55(8):527-32. PubMed ID: 25132947
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of total prostate specific antigen and free to total prostate specific antigen ratio in the diagnosis of prostate cancer.
Chakraborty L; Ahmed AN; Paul BK; Haque A; Ara A; Nabi S; Nessa M
Mymensingh Med J; 2012 Jan; 21(1):98-102. PubMed ID: 22314462
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen ratio correlates with aggressiveness of histology grades of prostate cancer.
Li W; Ren Y; Mee V; Wong PY
Clin Biochem; 1999 Feb; 32(1):31-7. PubMed ID: 10074889
[TBL] [Abstract][Full Text] [Related]
14. Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.
Stimac G; Reljic A; Spajic B; Dimanovski J; Ruzic B; Ulamec M; Sonicki Z; Kraus O
Scott Med J; 2009 Aug; 54(3):8-12. PubMed ID: 19725275
[TBL] [Abstract][Full Text] [Related]
15. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population.
Amirrasouli H; Kazerouni F; Sanadizade M; Sanadizade J; Kamalian N; Jalali M; Rahbar K; Karimi K
Urol J; 2010 Jun; 7(2):99-104. PubMed ID: 20535696
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
[TBL] [Abstract][Full Text] [Related]
17. Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
Hugosson J; Aus G; Bergdahl S; Fernlund P; Frösing R; Lodding P; Pihl CG; Lilja H
BJU Int; 2003 Dec; 92 Suppl 2():39-43. PubMed ID: 14983953
[TBL] [Abstract][Full Text] [Related]
18. Prostate Health Index outperforms other PSA derivatives in predicting a positive biopsy in men with tPSA <10 ng/mL: Largest prospective cohort in Taiwan.
Fan YH; Pan PH; Lin TP; Huang TH; Wei TC; Huang IS; Lin CC; Huang EYH; Chung HJ; Huang WJS
J Chin Med Assoc; 2019 Oct; 82(10):772-777. PubMed ID: 31356566
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen ratio: for diagnosis and assessment of aggressiveness of malignancy of prostate.
Kapoor N; Jain R; Surange S; Bhardwaj VK; Srivastava A
Indian J Pathol Microbiol; 2006 Apr; 49(2):178-81. PubMed ID: 16933710
[TBL] [Abstract][Full Text] [Related]
20. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
